Syros Pharmaceuticals, Inc.

Home » Syros Pharmaceuticals, Inc.

Secondary

Syros Pharmaceuticals, Inc.

They are pioneering the understanding of the non-coding region of the genome to advance a new wave of medicines that control expression of genes.

Symbol

SYRS

Last Closing Price
$10.45

Shares
3,800,000

Effective Date
January 31, 2018

Underwriters
J.P. Morgan, Cowen, Piper Jaffray

To view the prospectus for Syros Pharmaceuticals, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253